Download only This report presents information about Medicaid coverage of medication-assisted treatment for opioid and alcohol dependence. It covers treatment effectiveness and cost effectiveness. The report also offers examples of innovative approaches in Vermont, Massachusetts, and Maryland. Publication ID SMA14-4854 Publication Date November 2014 Format Report Download Medicaid: Financing Meds to Treat Alcohol, Opioid Use PDF 1.87 MB Find Related Information Audience Policymakers Program Planners, Administrators, & Project Managers Public Health Professionals Population Group People with Alcohol Use or Abuse Problems as Population Group People with Substance Use or Abuse Problems as Population Group You May Also Be Interested In Behavioral Health Equity Barometer, 2014 This report provides a snapshot of key aspects of behavioral health, serious mental illness, suicidal thoughts, and mental illness, substance use disorders, or both. The information is based on selected determinants of health, including race and ethnicity, income level, geography, and health insurance status. Advisory: Sublingual and Transmucosal Buprenorphine for Opioid Use Disorder: Review and Update This advisory summarizes data on the use of sublingual and transmucosal buprenorphine for the medication-assisted treatment of opioid use disorder. Medication-Assisted Treatment of Opioid Use Disorder Pocket Guide This guide is for physicians using medication-assisted treatment for patients with opioid use disorder. It discusses various types of approved medications, screening and assessment tools, and best practices for patient care. Medication-Assisted Treatment for Opioid Addiction in Opioid Treatment Programs This guide informs clinicians about medications for opioid use disorder treatment, including side effects, drug interactions, and take-home doses. It discusses patient counseling, associated medical issues, hepatitis C evaluation, drug testing, and pregnant women. A Collaborative Approach to the Treatment of Pregnant Women with Opioid Use Disorders This manual offers best practices to states, tribes, and local communities on collaborative treatment approaches for pregnant women living with opioid use disorders, and the risks and benefits associated with medication-assisted treatment. Advisory: An Introduction to Extended-Release Injectable Naltrexone for the Treatment of People with Opioid Dependence This advisory gives an overview of extended-release injectable naltrexone for people with opioid dependence. It discusses how it differs from other medication-assisted treatments, safety concerns, and patients most likely to benefit.